The prevalence of these gene alterations vary among CRC cases [393] where CTNNB1 mutations occur in about 10–15% of CRC cases, whereas AXIN2, TCF7L2, and LRP5/6 are relatively rare mutations but have been reported in a small percentage of cases [393,394]. Here, CTNNB1 is linked to colorectal carcinoma.